Related references
Note: Only part of the references are listed.Interleukin 15 and Eotaxin correlate with the outcome of breast cancer patients vice versa independent of CTC status
Theresa Vilsmaier et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2021)
The new role for an old guy: MYC as an immunoplayer
Dragan Marinkovic et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
Biological effects of IL-15 on immune cells and its potential for the treatment of cancer
Shuling Zhang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis
Andras Heczey et al.
NATURE MEDICINE (2020)
The Tumor Microenvironment in Neuroblastoma: New Players, New Mechanisms of Interaction and New Perspectives
Laurence Blavier et al.
CANCERS (2020)
Systematic assessment of the clinicopathological prognostic significance of tissue cytokine expression for lung adenocarcinoma based on integrative analysis of TCGA data
Yuanmei Dong et al.
SCIENTIFIC REPORTS (2019)
Interleukin-15 Enhances Anti-GD2 Antibody-Mediated Cytotoxicity in an Orthotopic PDX Model of Neuroblastoma
Rosa Nguyen et al.
CLINICAL CANCER RESEARCH (2019)
NKT Cells Coexpressing a GD2-Specific Chimeric Antigen Receptor and IL15 Show Enhanced In Vivo Persistence and Antitumor Activity against Neuroblastoma
Xin Xu et al.
CLINICAL CANCER RESEARCH (2019)
Eradication of Neuroblastoma by T Cells Redirected with an Optimized GD2-Specific Chimeric Antigen Receptor and Interleukin-15
Yuhui Chen et al.
CLINICAL CANCER RESEARCH (2019)
The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their ex vivo Expansion and Cytotoxic Potential Against Neuroblastoma: Perspective for Optimized Immunotherapy Post Haploidentical Stem Cell Transplantation
Annekathrin Heinze et al.
FRONTIERS IN IMMUNOLOGY (2019)
Invariant natural killer T infiltration in neuroblastoma with favorable outcome
Tomoro Hishiki et al.
PEDIATRIC SURGERY INTERNATIONAL (2018)
The MYC oncogene is a global regulator of the immune response
Stephanie C. Casey et al.
BLOOD (2018)
Clinically Relevant Cytotoxic Immune Cell Signatures and Clonal Expansion of T-Cell Receptors in High-Risk MYCN-Not-Amplified Human Neuroblastoma
Jun S. Wei et al.
CLINICAL CANCER RESEARCH (2018)
Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group
Amy K. Erbe et al.
CLINICAL CANCER RESEARCH (2018)
MYC: Master Regulator of Immune Privilege
Stephanie C. Casey et al.
TRENDS IN IMMUNOLOGY (2017)
MYCN amplification is associated with repressed cellular immunity in neuroblastoma: an In Silico immunological analysis of TARGET Database
Peng Zhang et al.
FRONTIERS IN IMMUNOLOGY (2017)
Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expression
Julian P. Layer et al.
ONCOIMMUNOLOGY (2017)
MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma
Elisa Brandetti et al.
ONCOIMMUNOLOGY (2017)
xCell: digitally portraying the tissue cellular heterogeneity landscape
Dvir Aran et al.
GENOME BIOLOGY (2017)
Tailored design of NKT-stimulatory glycolipids for polarization of immune responses
Jung-Tung Hung et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project
Daria Thompson et al.
CANCER (2016)
More than the genes, the tumor microenvironment in neuroblastoma
Lucia Borriello et al.
CANCER LETTERS (2016)
Interleukin-15: New kid on the block for antitumor combination therapy
Johan M. J. Van den Bergh et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
Advances in Risk Classification and Treatment Strategies for Neuroblastoma
Navin R. Pinto et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma
Marco Mina et al.
ONCOIMMUNOLOGY (2015)
Interleukin-15 in the treatment of cancer
Thomas A. Waldmann
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2014)
A Novel Function of Adipocytes in Lipid Antigen Presentation to iNKT Cells
Jin Young Huh et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Neuroblastoma and MYCN
Miller Huang et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity
Daofeng Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
IL-15 Regulates Homeostasis and Terminal Maturation of NKT Cells
Laura E. Gordy et al.
JOURNAL OF IMMUNOLOGY (2011)
microRNA Signature and Expression of Dicer and Drosha Can Predict Prognosis and Delineate Risk Groups in Neuroblastoma
Ruey-Jen Lin et al.
CANCER RESEARCH (2010)
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma.
Alice L. Yu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
V alpha 24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages
Liping Song et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Chemokine Markers Predict Biochemical Recurrence of Prostate Cancer following Prostatectomy
David L. Blum et al.
CLINICAL CANCER RESEARCH (2008)
Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids
Ya-Jen Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma
Liping Song et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design
Thomas A. Waldmann
NATURE REVIEWS IMMUNOLOGY (2006)
The MYCN enigma:: Significance of MYCN expression in neuroblastoma
XX Tang et al.
CANCER RESEARCH (2006)
Distinct homeostatic requirements of CD4+ and CD4- subsets of Vα24-invariant natural killer T cells in humans
DV Baev et al.
BLOOD (2004)
Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2
LS Metelitsa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Interleukin 15: biology and relevance to human disease
TA Fehniger et al.
BLOOD (2001)
Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice
MK Kennedy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
